StockNews.com upgraded shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday morning.
Other equities research analysts have also recently issued reports about the company. Oppenheimer cut Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th. BTIG Research lowered Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th. Finally, B. Riley began coverage on Tactile Systems Technology in a research report on Thursday, September 26th. They issued a “buy” rating and a $23.00 price objective for the company.
Read Our Latest Stock Report on TCMD
Tactile Systems Technology Stock Down 1.9 %
Institutional Trading of Tactile Systems Technology
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Arcadia Investment Management Corp MI purchased a new position in Tactile Systems Technology in the 3rd quarter valued at about $29,000. Gladius Capital Management LP acquired a new position in shares of Tactile Systems Technology during the third quarter valued at approximately $44,000. Quarry LP purchased a new position in shares of Tactile Systems Technology in the second quarter valued at approximately $46,000. Magnetar Financial LLC acquired a new stake in shares of Tactile Systems Technology in the second quarter worth approximately $130,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Tactile Systems Technology during the third quarter worth approximately $156,000. Hedge funds and other institutional investors own 83.43% of the company’s stock.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Stories
- Five stocks we like better than Tactile Systems Technology
- Are Penny Stocks a Good Fit for Your Portfolio?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Top Stocks Investing in 5G Technology
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.